OCTA (Optical Coherence Angiography Tomography) Versus Structural OCT(Optical Coherence Tomography) in Neovascular AMD (Age Macular Degeneration)
NCT ID: NCT03939195
Last Updated: 2020-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
130 participants
OBSERVATIONAL
2018-12-01
2020-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Optical Coherence Tomography.
NCT01080898
Dual Wavelength OCT
NCT03843840
CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea (COCTAEyl)
NCT03803631
Retinal Investigation Using Optos OCT Device
NCT06846151
Association Between Retinal Microvasculature and Optic Disc Alterations in Non-pathological High Myopia With OCTA
NCT04631991
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The fractal dimension of a vascular structure corresponds to its degree of complexity. Fractals are models found in nature and biological systems that show self-similarity at different magnifications. It is obtained from the "box counting" method calculating the number of vascular segments contained in squares of varied size. Normal retinal vessels have a known and quantified complexity (FD = 1.7).
A neovascular tumor treated with anti-angiogenics will reduce vascular density, losing its random architecture; the investigators observe a return to a model standardized. NVCs have a random organization. The lower the FD, the more random the vascular architecture.
Lacunarity represents the texture or the homogeneity of a lesion, this one is heterogeneous when it is little vascularized and homogeneous if the vascularization is very dense. The lower the lake, the more homogeneous the lesion.
FD and Lac are obtained in Angiography Optical Coherence Tomography (OCTA) by the analysis of the hypersignal detected on the cut of the external retina.
The image is automatically binarised and skeletonized. NVC delineation is automatic and associated with automatic background noise processing. This software is fully automatic whose inter and intra grader reproducibility will be evaluated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Follow-up
4 follow-up visits with OCT Angiography and Structural OCT B
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Showing type 1 or type 2 CNV (choroidal neovessel) related to AMD during the second year of follow-up.
* Acceptance to participate in the protocol
* Affiliated to a social security scheme
Exclusion Criteria
* Other cause of CNV
* Signal less than 80 decibel and detachment of pigment epithelium (PED) greater than 250 μm on structural OCT B.
* Protected Majors (Guardianship, Curator, Safeguard of Justice)
* Participation in another interventional research.
* Refusal to participate in the study
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Intercommunal Creteil
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHI Créteil
Créteil, , France
Centre Bergouignan
Évreux, , France
Centre d'exploration ophtalmologique de l'odéon
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A00948-47
Identifier Type: OTHER
Identifier Source: secondary_id
QUAOBARE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.